Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)

Published:2019-04 Issue:8 Volume:123 Page:1193-1201
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Sharma Abhinav^ORCID,Sun Jie-Lena,Lokhnygina Yuliya,Roe Matthew T.,Ahmad Tariq,Desai Nihar R.,Blazing Michael A.

Funder

Merck

Bayer

Alberta Innovates

European Society of Cardiology

Roche

Agency for Healthcare Research and Quality

Centers for Medicare & Medicaid Services

Johnson & Johnson

Medtronic

Yale University

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Cardiovascular risk prediction in patients with stable and unstable coronary heart disease;Morrow;Circulation,2010

2. Atherothrombotic risk stratification and the efficacy and safety of vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction;Bohula;Circulation,2016

3. Atherothrombotic risk stratification and ezetimibe for secondary prevention;Bohula;J Am Coll Cardiol,2017

4. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Amsterdam;J Am Coll Cardiol,2014

5. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;J Am Coll Cardiol,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ezetimibe use and mortality after myocardial infarction: A nationwide cohort study;American Journal of Preventive Cardiology;2024-09

2. Assessment and modification of cardiovascular risk in non-cardiac surgery. Clinical guidelines 2023;Russian Journal of Cardiology;2023-09-23

3. Uncovering heterogeneous cardiometabolic risk profiles in US adults: the role of social and behavioral determinants of health;BMJ Open Diabetes Research & Care;2023-09

4. EVALUATING SOCIAL DETERMINANTS OF HEALTH VARIABLES IN ADVANCED ANALYTIC AND ARTIFICIAL INTELLIGENCE MODELS FOR CARDIOVASCULAR DISEASE RISK AND OUTCOMES: A TARGETED REVIEW;ETHNIC DIS;2023

5. Evaluating Social Determinants of Health Variables in Advanced Analytic and Artificial Intelligence Models for Cardiovascular Disease Risk and Outcomes: A Targeted Review;Ethnicity and Disease;2023-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3